Shopping Cart
Remove All
Your shopping cart is currently empty
JPM-OEt is a broad-spectrum cysteine cathepsin inhibitor with antitumor activity that binds covalently at the active site, irreversibly inhibiting the cysteine cathepsin family.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
| Description | JPM-OEt is a broad-spectrum cysteine cathepsin inhibitor with antitumor activity that binds covalently at the active site, irreversibly inhibiting the cysteine cathepsin family. |
| In vivo | JPM-OEt (50 mg/kg; i.p.; daily for 30 days) significantly decreases tumor cathepsin B activity[1]. JPM-OEt (50 mg/kg; i.p.; twice daily for 4 weeks) induces tumor regression in the RIP1-Tag2 (RT2) mouse model of pancreatic islet cell tumorigenesis[2]. JPM-OEt (50 mg/kg; i.p.; daily from 63 to 98 days) significantly delays tumor burden increase during the first 2 weeks of treatment[3]. |
| Molecular Weight | 392.45 |
| Formula | C20H28N2O6 |
| Cas No. | 262381-84-0 |
| Smiles | CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCc1ccc(O)cc1 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.